| Literature DB >> 29910628 |
Abstract
Diabetes is associated with various complications and reduced quality of life. Of the many complications, some are life-threatening. Among these, foot complications remain an important concern. The major foot complications include foot ulceration, cellulitis, abscess, wet gangrene, dry gangrene, and necrotizing fasciitis, with different pathophysiological concepts behind each of them. Gangrene occurs due to reduced blood supply in the body tissues that leads to necrosis. This condition may arise because of an injury, infection, or other health conditions, majorly diabetes. Gangrene is classified as dry, wet, and gas gangrene. In case of wet and gas gangrene, surgical amputation is usually performed to prevent the spread of infection to other tissues. In dry gangrene, due to the presence of clear demarcation, autoamputation is preferred in certain parts of the globe. The present review aims to analyze the mode of dry gangrene management in diabetic patients based on previous evidence and plans to highlight various management strategies available for dry gangrene and the advantages/disadvantages of different treatments with special consideration to autoamputation.Entities:
Keywords: amputation; diabetic foot; diabetic toe; dry gangrene; foot care; surgical amputation
Year: 2018 PMID: 29910628 PMCID: PMC5987754 DOI: 10.2147/DMSO.S164199
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Differences in features of dry gangrene, wet gangrene, and gas gangrene
| Feature | Dry gangrene | Wet gangrene | Gas gangrene |
|---|---|---|---|
| Site | Commonly limbs | More common in bowel | Limbs |
| Mechanism | Arterial occlusion | More commonly venous obstruction | Gases produced by |
| Macroscopy | Organ dry, shrunken, and black | Part moist, soft, swollen, rotten, and dark | Organ red, cold, pale, numb, shriveled up, and auto-amputation |
| Putrefaction | Limited due to very little blood supply | Marked due to congestion of organ with blood | Marked due to bacteria and infiltration of gases produced by them in tissues |
| Line of demarcation | Present at the junction between healthy and gangrenous parts | No clear-cut line of demarcation | No clear-cut line of demarcation |
| Bacteria | Bacteria fail to survive | Numerous present | Major cause |
| Prognosis | Generally better due to little septicemia | Generally poor due to profound toxemia | Generally poor due to quick spread to the surrounding tissues |
Note: Data from NHP.gov.in.11
Figure 1The pathophysiological pathways of dry gangrene
Note: Adapted from: Rodrigues J, Mitta N.24
Pharmacologic approaches for gangrene management
| Pharmacologic approach | Drugs class examples | Mechanism of action |
|---|---|---|
| Pain management | Opioids and opioid-like analgesics Morphine, oxycodone, dextromethorphan, tapentadol, tramadol | Mimic the actions of endogenous opioid peptides by interacting with mu, delta, or kappa opioid receptors |
| Topical medications: capsaicin, lidocaine | Provide local action on the skin to relieve pain | |
| Circulation management | Antiplatelet agents: aspirin, clopidogrel, prasugrel, ticlopidine, dipyridamole, abciximab, eptifibatide, tirofiban, ticagrelor, vorapaxar | Prevent the aggregation of platelets and fibrinogenesis |
| Anticoagulants: heparin, fondaparinux, danaparoid, bishydroxycoumarin, warfarin, acenocoumarol, phenindione | Cause activation of anticlotting factors, direct inhibition of thrombin, inhibition of synthesis of blood coagulation factor precursors (zymogens), and activation of protein C | |
| Fibrinolytic agents: streptokinase, urokinase, alteplase, reteplase, tenecteplase | Cause lysis of thrombi/clot to recanalize the occluded vessels | |
| Antibiotics | Penicillins: flucloxacillin | Inhibit bacterial cell wall synthesis by binding to specific penicillin-binding proteins located inside the bacterial cell wall |
| Fluoroquinones: ciprofloxacin | Inhibit topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, strand supercoiling repair, and recombination | |
| Antiprotozoals: metronidazole | In reduced form, they covalently bind to DNA, disrupt its helix structure, inhibit bacterial nucleic acid synthesis, and cause bacterial cell death | |
| Carbapenems: ertapenem, meropenem | Show bactericidal activity by inhibiting the bacterial cell wall synthesis | |
| Glycopeptides: teicoplanin, vancomycin | Inhibit the bacterial cell wall synthesis and cause cell death | |
| Tetracyclines: doxycycline | Reversibly bind to 30S ribosomal subunits and possibly to 50S subunits, block the binding of aminoacyl tRNA to mRNA, and inhibit bacterial protein synthesis | |
| Lincosamides: clindamycin | Inhibit bacterial protein synthesis by binding to 50S ribosomal subunits of the bacteria | |
| Oxazolidinones: linezolid | Selectively inhibit bacterial protein synthesis by binding to bacterial ribosomes and prevent the formation of a functional 70S initiation complex |
Note: Data taken from Tripathi,36 NHS.org.,37 and Drugbank.ca.38
Figure 2Management of dry gangrene.
Note: Adapted from: Rodrigues J, Mitta N.24
Abbreviations: SPP, skin perfusion pressure; SVR, skin vascular resistance.